Q16531 (DDB1_HUMAN) Homo sapiens (Human)
DNA damage-binding protein 1 UniProtKBInterProSTRINGInteractive Modelling
Available Structures
147 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structure of the hsDDB1-drDDB2 complex |
Heteromer Q2YDS1; | 100.0 | 1×PG4; | |||
| Structural basis of Lenalidomide induced CK1a degradation by the crl4crbn ubiquitin ligase |
Heteromer P48729; Q96SW2; | 100.0 | 1×ZN; 1×LVY; | |||
| Crystal structure of human CRBN-DDB1 in complex with Pomalidomide |
Heteromer Q96SW2; | 100.0 | 6×EDO; 1×ZN; 1×Y70; | |||
| Crystal structure of SIV Vpr,fused to T4 lysozyme, isolated from moustached monkey, bound to human … |
Heteromer A4UDG5; P00720; Q9Y4B6; | 100.0 | 8×GOL; 1×ZN; | |||
| Structure of hsDDB1-drDDB2 bound to a 16 bp abasic site containing DNA-duplex |
Heteromer Q2YDS1; | 100.0 | 1×PG4; | |||
| Crystal structure of human CRBN-DDB1 in complex with compound 4 |
Heteromer Q96SW2; | 100.0 | 9×EDO; 1×ZN; 1×VP9; | |||
| Crystal Structure of DDB1 in Complex with the H-Box Motif of WDR21A |
Heteromer Q8WV16; | 99.73 | ||||
| Crystal Structure of DDB1 in Complex with the H-Box Motif of WDTC1 |
Heteromer Q8N5D0; | 99.73 | ||||
| Crystal Structure of DDB1 in Complex with the H-Box Motif of DDB2 |
Heteromer Q92466; | 99.73 | ||||
| Structure of hsDDB1-drDDB2 bound to a 14 bp 6-4 photoproduct containing DNA-duplex |
Heteromer Q2YDS1; | 100.0 | 1×PG4; | |||
| Crystal Structure of DDB1 in Complex with the H-Box Motif of WHX |
Heteromer P03167; | 99.73 | ||||
| Crystal Structure of DDB1 in Complex with the H-Box Motif of IQWD1 |
Heteromer Q58WW2; | 99.73 | ||||
| Crystal Structure of DDB1 In Complex with Simian Virus 5 V Protein |
Heteromer P11207; | 99.73 | 2×ZN; | |||
| Structure of DDB1-DDA1-DCAF15 complex bound to E7820 and RBM39 |
Heteromer Q14498; Q66K64; Q9BW61; | 100.0 | 1×OXM; 1×O6M; 1×ZN; | |||
| Structure of DDB1-DDA1-DCAF15 complex bound to tasisulam and RBM39 |
Heteromer Q14498; Q66K64; Q9BW61; | 100.0 | 1×P7M; 1×ZN; | |||
| Structure of DDB1-DDA1-DCAF15 complex bound to Indisulam and RBM39 |
Heteromer Q14498; Q66K64; Q9BW61; | 100.0 | 1×EF6; 1×ZN; | |||
| Crystal Structure of DDB1 in Complex with the H-Box Motif of HBX |
Heteromer Q80IU5; | 99.73 | ||||
| Structure of the human DDB1-CSA complex |
Heteromer Q13216; | 100.0 | ||||
| Structure of DDB1 bound to DS17-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 5×GOL; 1×RQL; | |||
| Crystal Structure of DDB1 in Complex with the H-Box Motif of WDR22 |
Heteromer Q96JK2; | 99.73 | ||||
| Crystal Structure of DDB1 in Complex with the H-Box Motif of WDR40A |
Heteromer Q5T6F0; | 99.73 | ||||
| Structure of DDB1 bound to DS16-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 10×SO4; 1×RNF; | |||
| Structure of DDB1 bound to DS22-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 5×SO4; 1×RQL; | |||
| Crystal structure of DDB1 in complex with DET1- and DDB1-associated protein 1 (DDA1) |
Heteromer Q9BW61; | 100.0 | ||||
| Crystal structure of human DDB1 bound to human DCAF1 (amino acid residues 1046-1396) |
Heteromer Q9Y4B6; | 100.0 | ||||
| Structure of hsDDB1-drDDB2 bound to a 15 bp CPD-duplex (purine at D-1 position) at 3.1 A resolution… |
Heteromer Q2YDS1; | 99.91 | 1×CA; | |||
| Crystal Structure of the DDB1-Cul4A-Rbx1-SV5V Complex |
Heteromer P11207; P62877; Q13619; | 99.74 | 5×ZN; | |||
| Structure of DDB1 bound to DS18-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 12×SO4; 1×RVQ; | |||
| Structure of DDB1 bound to SR-4835-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 1×SO4; 1×RMF; 1×CIT; | |||
| Ternary complex structure of Cereblon-DDB1 bound to IKZF2(ZF2) and the molecular glue DKY709 |
Heteromer Q53SU9; Q96SW2; | 100.0 | 2×ZN; 1×LWK; 4×SO4; | |||
| Structure of DDB1 bound to 919278-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 2×CIT; 1×RVH; | |||
| Structure of DDB1 bound to DS43-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 2×CIT; 1×RQ9; | |||
| Structure of DDB1 bound to Z7-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 10×SO4; 1×RP9; | |||
| Structure of DDB1 bound to 21195-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 1×EDO; 1×RS5; 10×SO4; | |||
| Structure of DDB1-CRBN-pomalidomide complex bound to IKZF1(ZF2) |
Heteromer Q13422; Q96SW2; | 100.0 | 2×ZN; 1×Y70; | |||
| Structure of DDB1 bound to DS61-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 7×SO4; 1×RQ5; | |||
| Structure of DDB1 bound to Z11-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 12×SO4; 1×RVU; | |||
| Structure of DDB1 bound to DS59-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 5×SO4; 1×RMX; | |||
| Structure of the hsDDB1-hsDDB2 complex |
Heteromer Q92466; | 99.74 | ||||
| Structure of DDB1 bound to Z12-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 12×SO4; 1×RW6; | |||
| Structure of the hsDDB1-hsCSA complex |
Heteromer Q13216; | 100.0 | ||||
| Crystal structure of DDB1-CRBN-BRD4(BD1) complex bound to dBET6 PROTAC. |
Heteromer O60885; Q96SW2; | 100.0 | 1×ZN; 1×RN6; | |||
| Structure of DDB1 bound to DS15-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 11×SO4; 1×T6X; | |||
| Crystal Structure of DDB1 in Complex with the H-Box Motif of WDR42A |
Heteromer Q5TAQ9; | 99.73 | ||||
| Structure of DDB1 bound to DS11-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 1×EDO; 8×SO4; 1×RSU; | |||
| Structure of DDB1 bound to DS30-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 11×SO4; 1×RWN; | |||
| Structure of DDB1 bound to DS08-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 7×SO4; 1×RWE; | |||
| Structure of DDB1 bound to dCeMM4-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 2×CIT; 1×RNU; | |||
| Structure of DDB1 bound to DS19-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 1×EDO; 6×SO4; 1×RSI; | |||
| Structure of DDB1 bound to DS55-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 2×SO4; 1×RQE; | |||
| Structure of DDB1 bound to CR8-engaged CDK12-cyclinK |
Heteromer O75909; Q9NYV4; | 100.0 | 1×RC8; | |||
| The X-ray structure of the DDB1-DCAF1-Vpr-UNG2 complex |
Heteromer P12520; P13051; Q9Y4B6; | 100.0 | ||||
| Structure of DDB1 bound to DRF-053-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 1×EDO; 7×SO4; 1×RV6; | |||
| Crystal structure of DDB1-CRBN-BRD4(BD1) complex bound to dBET23 PROTAC. |
Heteromer O60885; Q96SW2; | 100.0 | 1×ZN; 1×RN3; | |||
| Structure of DDB1 bound to roscovitine-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 5×SO4; 1×RRC; | |||
| Structure of DDB1 bound to HQ461-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 2×CIT; 1×RPW; | |||
| Structure of DDB1 bound to DS24-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 9×SO4; 1×RLC; | |||
| Structure of hsDDB1-drDDB2 bound to a 16 bp CPD-duplex (pyrimidine at D-1 position) at 3.6 A resolu… |
Heteromer Q2YDS1; | 99.87 | 1×CA; | |||
| Structure of DDB1 bound to DS06-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 5×SO4; 1×RUW; | |||
| Structure of DDB1 bound to DS50-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 7×SO4; 1×RQU; | |||
| Crystal structure of DDB1-CRBN-ALV1 complex bound to Helios (IKZF2 ZF2) |
Heteromer Q96SW2; Q9UKS7; | 100.0 | 2×ZN; 1×RN9; | |||
| Structure of DDB1 bound to WX3-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 5×SO4; 1×RR9; | |||
| Structure of DDB1 bound to dCeMM3-engaged CDK12-cyclin K |
Heteromer O75909; Q9NYV4; | 100.0 | 4×SO4; 1×RKO; | |||
| Structure of DDB1/Cdk12/Cyclin K with molecular glue SR-4835 |
Heteromer O75909; Q9NYV4; | 100 | 3×RMF; | |||
| Crystal structure of DDB1-CRBN-BRD4(BD1) complex bound to dBET55 PROTAC. |
Heteromer O60885; Q96SW2; | 100.0 | 1×ZN; | |||
| Structure of the DDB1-CRBN-pomalidomide complex bound to ZNF692(ZF4) |
Heteromer Q96SW2; Q9BU19; | 100.0 | 2×ZN; 1×Y70; | |||
| Crystal structure of DDB1-CRBN-BRD4(BD1) complex bound to dBET70 PROTAC |
Heteromer O60885; Q96SW2; | 100.0 | 1×ZN; | |||
| STRUCTURE OF DDB1-DDB2-CUL4A-RBX1 BOUND TO A 12 BP ABASIC SITE CONTAINING DNA-DUPLEX |
Heteromer P62878; Q13619; Q2YDS1; | 100.0 | ||||
| Crystal structure of DDB1-CRBN-BRD4(BD1) complex bound to dBET57 PROTAC |
Heteromer O60885; Q96SW2; | 100.0 | 1×ZN; | |||
| Structure of DDB1-DDB2-CUL4B-RBX1 bound to a 12 bp abasic site containing DNA-duplex |
Heteromer P62878; Q13620; Q2YDS1; | 100.0 | ||||
| Cryo-EM structure of NCP_THF2(-3)-UV-DDB |
Heteromer P04908; P06899; P62805; P68431; Q92466; | 100.0 | ||||
| Cereblon~DDB1 bound to Pomalidomide |
Heteromer Q96SW2; | 100.0 | 1×ZN; 1×Y70; | |||
| Cryo-EM structure of DDB1dB:CRBN:PT-179:SD40, conformation 2 |
Heteromer Q13422; Q96SW2; | 100.0 | 2×ZN; 1×MIQ; | |||
| Cereblon-DDB1 in the Apo form with DDB1 in the twisted conformation |
Heteromer Q96SW2; | 100.0 | 1×ZN; | |||
| Cryo-EM structure of NCP-6-4PP(-1)-UV-DDB |
Heteromer P04908; P06899; P62805; P68431; Q92466; | 100.0 | ||||
| Cereblon-DDB1 bound to CC-92480 and Ikaros ZF1-2-3 |
Heteromer Q13422; Q96SW2; | 100.0 | 2×ZN; 1×QFC; | |||
| Cryo-EM structure of NCP-THF2(+1)-UV-DDB class B |
Heteromer P04908; P06899; P62805; P68431; Q92466; | 100.0 | ||||
| Structure of human DDB1-DCAF12 in complex with the C-terminus of CCT5 |
Heteromer P48643; Q5T6F0; | 100 | ||||
| Negative-stain electron microscopy structure of DDB1-DCAF12-CCT5 |
Heteromer P48643; Q5T6F0; | 100 | ||||
| Cryo-EM Structure of the DDB1-DCAF1-CUL4A-RBX1 Complex |
Heteromer P62877; Q13619; Q9Y4B6; | 100.0 | ||||
| CryoEM structure of DDB1-VprBP-Vpr-UNG2(94-313) complex |
Heteromer P12520; P13051; Q9Y4B6; | 100.0 | ||||
| Cryo-EM structure of NCP_THF2(-1)-UV-DDB |
Heteromer P04908; P06899; P62805; P68431; Q92466; | 100.0 | ||||
| Cereblon-DDB1 in the Apo form |
Heteromer Q96SW2; | 100.0 | 1×ZN; | |||
| Structure of the human DDB1-DCAF12 complex |
Heteromer Q5T6F0; | 100 | ||||
| Cryo-EM structure of DDB1dB:CRBN:PT-179:SD40, conformation 1 |
Heteromer Q13422; Q96SW2; | 100.0 | 2×ZN; 1×MIQ; | |||
| Cryo-EM structure of NCP-THF2(+1)-UV-DDB class A |
Heteromer P04908; P06899; P62805; P68431; Q92466; | 100.0 | ||||
| Cereblon~DDB1 bound to Iberdomide and Ikaros ZF1-2-3 |
Heteromer Q13422; Q96SW2; | 100.0 | 2×ZN; 1×8W7; | |||
| CryoEM structure of UVSSA(VHS)-CSA-DDB1-DDA1 |
Heteromer Q13216; Q2YD98; Q9BW61; | 100.0 | ||||
| Cryo-EM structure of RCMV-E E27 bound to human DDB1 (deltaBPB) and full-length rat STAT2 |
Heteromer K7Y9Z1; Q5XI26; | 100.0 | 1×ZN; | |||
| Pol II-CSB-CSA-DDB1-ELOF1 |
Heteromer A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A8D1B522; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P60899; Q03468; Q13216; | 100.0 | 9×ZN; 1×MG; | |||
| Cryo-EM structure of RCMV-E E27 bound to human DDB1 (deltaBPB) and rat STAT2 CCD |
Heteromer K7Y9Z1; Q5XI26; | 100.0 | 1×ZN; | |||
| Structure of the human DDB1-DDA1-DCAF15 E3 ubiquitin ligase bound to RBM39 and Indisulam |
Heteromer Q14498; Q66K64; Q9BW61; | 100.0 | 1×EF6; | |||
| CryoEM structure of DDB1-VprBP complex in ARM-up conformation |
Heteromer Q9Y4B6; | 100.0 | ||||
| Cereblon~DDB1 bound to CC-92480 with DDB1 in the twisted conformation |
Heteromer Q96SW2; | 100.0 | 1×ZN; 1×QFC; | |||
| C(N)RL4CSA-UVSSA-E2-ubiquitin complex. |
Heteromer A0A6P5C4T4; P0CG48; P62877; Q13216; Q13619; Q15843; Q2YD98; | 100.0 | 3×ZN; | |||
| Cereblon~DDB1 in the Apo form with DDB1 in the hinged conformation |
Heteromer Q96SW2; | 100.0 | 1×ZN; | |||
| CRL4CSA-E2-Ub (state 2) |
Heteromer P0CG48; P62837; P62877; Q13216; Q13619; Q15843; | 100.0 | 3×ZN; | |||
| Cereblon~DDB1 bound to CC-92480 with DDB1 in the linear conformation |
Heteromer Q96SW2; | 100.0 | 1×ZN; 1×QFC; | |||
| Cereblon~DDB1 bound to CC-92480 with DDB1 in the hinged conformation |
Heteromer Q96SW2; | 100.0 | 1×ZN; 1×QFC; | |||
| Structure of the Pol II-TCR-ELOF1 complex. |
Heteromer A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A8D1B522; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P60899; Q03468; Q13216; Q2YD98; | 100.0 | 10×ZN; 2×MG; 1×ADP; 1×BEF; | |||
| Degrader-induced complex between PTPN2 and CRBN-DDB1 |
Heteromer P17706; Q96SW2; | 100.0 | 1×WO8; 1×ZN; | |||
| Pol II-CSB-CRL4CSA-UVSSA-SPT6-PAF (Structure 4) |
Heteromer A0A4X1TRS6; A0A4X1VEK9; A0A4X1VM56; A0A4X1VYD0; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P11414; P60899; P62878; Q03468; Q13216; Q13619; Q2YD98; Q6P1J9; Q6PD62; Q7KZ85; Q8N7H5; Q8WVC0; Q9GZS3; | 100.0 | 8×ZN; 1×MG; | |||
| Pol II-CSB-CSA-DDB1-UVSSA (Structure1) |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P11414; P60899; Q03468; Q13216; Q2YD98; | 100.0 | 8×ZN; 1×MG; | |||
| Pol II-CSB-CSA-DDB1-UVSSA-PAF-SPT6 (Structure 3) |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P11414; P60899; Q03468; Q13216; Q2YD98; Q6P1J9; Q6PD62; Q7KZ85; Q8N7H5; Q8WVC0; Q9GZS3; | 100.0 | 8×ZN; 1×MG; | |||
| Pol II-CSB-CRL4CSA-UVSSA-SPT6-PAF (Structure 5) |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P11414; P60899; P62878; Q03468; Q13216; Q13619; Q2YD98; Q6P1J9; Q6PD62; Q7KZ85; Q8N7H5; Q8WVC0; Q9GZS3; | 100.0 | 8×ZN; 1×MG; | |||
| Pol II-CSB-CSA-DDB1-UVSSA-ADPBeF3 (Structure2) |
Heteromer A0A4X1TRS6; A0A4X1VEK9; A0A4X1VM56; A0A4X1VYD0; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P11414; P60899; Q03468; Q13216; | 100.0 | 8×ZN; 2×MG; 1×ADP; 1×BEF; | |||
| Structure of Pol II-TC-NER-STK19 complex |
Heteromer A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A4X1VYD0; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P49842; P60002; P60899; Q03468; Q13216; Q2YD98; Q9BW61; | 100.0 | 10×ZN; 1×MG; | |||
| PolII-TCR-STK19 structure. |
Heteromer A0A287ADR4; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; A0A8D0JYF1; A0A8D1KNW4; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P49842; P60002; P60899; Q03468; Q13216; Q2YD98; | 100.0 | 11×ZN; 2×MG; 1×ADP; 1×BEF; | |||
| Crystal structure of full-length human DCAF15-DDB1(deltaBPB)-DDA1-RBM39 in complex with indisulam |
Heteromer Q14498; Q66K64; Q9BW61; | 100 | 2×GOL; 1×EF6; | |||
| Crystal structure of full-length human DCAF15-DDB1-deltaPBP-DDA1-RBM39 in complex with 4-(aminometh… |
Heteromer Q14498; Q66K64; Q9BW61; | 100 | 1×Q5J; 1×GOL; | |||
| Damaged DNA induced UV-damaged DNA-binding protein (UV-DDB) dimerization and its roles in chromatin… |
Heteromer Q92466; | 100 | ||||
| The ternary complex structure of DDB1-CRBN-SALL4(ZF1,2)-short bound to Pomalidomide |
Heteromer Q96SW2; Q9UJQ4; | 100.0 | 3×ZN; 1×Y70; | |||
| Structure of the human DDB1-DDA1-DCAF15 E3 ubiquitin ligase bound to RBM39 and sulfonamide E7820 |
Heteromer Q14498; Q66K64; Q9BW61; | 100.0 | 2×EPE; 1×O6M; 1×ZN; | |||
| Crystal Structure of DDB1 in Complex with the H-Box Motif of pUL145 |
Heteromer F5HF44; | 100.0 | ||||
| Structure of the DDB1-CRBN E3 ubiquitin ligase bound to lenalidomide |
Heteromer P0CF65; | 100.0 | 1×ZN; 1×LVY; | |||
| The ternary complex structure of DDB1-CRBN-SALL4(ZF1,2)-short bound to CC-220 |
Heteromer Q96SW2; Q9UJQ4; | 100.0 | 3×ZN; 1×8W7; 6×SO4; | |||
| Ternary complex structure of Cereblon-DDB1 bound to WIZ(ZF7) and the molecular glue WIZ-5 |
Heteromer O95785; Q96SW2; | 100.0 | 2×ZN; 1×SO4; 1×A1A5H; | |||
| Structure of the DDB1-CRBN E3 ubiquitin ligase bound to thalidomide |
Heteromer P0CF65; | 100.0 | 1×ZN; 1×EF2; | |||
| Structure of hsDDB1-drDDB2 bound to a 13 bp CPD-duplex (purine at D-1 position) at 3.0 A resolution… |
Heteromer Q2YDS1; | 99.91 | 2×MES; 2×CA; | |||
| Crystal Structure of Human Cereblon in Complex with DDB1 and Lenalidomide |
Heteromer Q96SW2; | 100.0 | 1×ZN; 1×LVY; | |||
| Ternary complex structure of Cereblon-DDB1 bound to WIZ(ZF7) and the molecular glue dWIZ-1 |
Heteromer O95785; Q96SW2; | 100.0 | 2×ZN; 1×U3I; 2×SO4; 1×EDO; | |||
| Cereblon in complex with DDB1 and CC-220 |
Heteromer Q96SW2; | 100.0 | 1×8W7; 1×ZN; | |||
| Damaged DNA induced UV-damaged DNA-binding protein (UV-DDB) dimerization and its roles in chromatin… |
Heteromer Q92466; | 100 | ||||
| Ternary complex structure of Cereblon-DDB1 bound to WIZ(ZF7) and the molecular glue WIZ-6 |
Heteromer O95785; Q96SW2; | 100.0 | 2×ZN; 1×SO4; 1×A1A5I; | |||
| Structure with SJ3149 |
Heteromer P48729; Q96SW2; | 100.0 | 1×ZN; 1×YOT; | |||
| Structure of the DDB1-CRBN E3 ubiquitin ligase bound to Pomalidomide |
Heteromer P0CF65; | 100.0 | 1×ZN; 1×Y70; | |||
| Structural Basis for Thalidomide Teratogenicity Revealed by the Cereblon-DDB1-SALL4-Pomalidomide Co… |
Heteromer Q96SW2; Q9UJQ4; | 100.0 | 2×ZN; 1×Y70; | |||
| Cereblon in complex with DDB1, CC-885, and GSPT1 |
Heteromer P15170; Q96SW2; | 100.0 | 1×ZN; 1×85C; | |||
| Cereblon in complex with DDB1, CC-90009, and GSPT1 |
Heteromer P15170; Q96SW2; | 100.0 | 1×V4M; 1×ZN; | |||
| Ternary complex structure of Cereblon-DDB1 bound to IKZF2(ZF2,3) and the molecular glue DKY709 |
Heteromer Q96SW2; Q9UKS7; | 100.0 | 3×ZN; 1×LWK; | |||
| Cryo-EM structure of DDB1dB:CRBN:Pomalidomide:SD40 |
Heteromer Q13422; Q96SW2; | 100.0 | 2×ZN; 1×Y70; | |||
| Structure of the DDB1-AMBRA1 E3 ligase receptor complex linked to cell cycle regulation |
Heteromer Q9C0C7; | 100.0 | ||||
| Structure of the human DDB1-DDA1-DCAF15 E3 ubiquitin ligase bound to compound furan 24 |
Heteromer Q66K64; Q9BW61; | 100.0 | 1×A1H18; | |||
| Ternary structure of intramolecular bivalent glue degrader IBG1 bound to BRD4 and DCAF16:DDB1deltaB… |
Heteromer O60885; Q9NXF7; | 100.0 | 1×ZN; 1×U79; | |||
| Cryo-EM structure of DDB1deltaB-DDA1-DCAF5 |
Heteromer Q96JK2; Q9BW61; | 100.0 | ||||
| CryoEM structure of human DDB1-DCAF12 in complex with MAGEA3 |
Heteromer P43357; Q5T6F0; | 100.0 | ||||
| The ternary complex structure of DDB1-CRBN-SALL4(ZF1,2)-long bound to Pomalidomide |
Heteromer Q96SW2; Q9UJQ4; | 100.0 | 3×ZN; 1×Y70; | |||
| Cryo-EM structure of DDB1deltaB-DDA1-DCAF16-BRD4(BD2)-MMH2 |
Heteromer O60885; Q9BW61; Q9NXF7; | 100.0 | 1×ZN; 1×YK3; | |||
| Structure of hsDDB1-drDDB2 bound to a 16 bp CPD-duplex (pyrimidine at D-1 position) at 3.8 A resolu… |
Heteromer Q2YDS1; | 99.91 | ||||
| Structure of the human DDB1-DDA1-DCAF15 E3 ubiquitin ligase bound to compound furan 12 |
Heteromer Q66K64; Q9BW61; | 100.0 | 1×A1H17; | |||
| Co-crystal structure of human DDB1 bound to fragment UB028671 | monomer | 100.0 | 2×TLA; 1×A1ALA; 6×EDO; 2×UNX; | |||
| Co-crystal structure of human DDB1 bound to fragment UB028669 | monomer | 100.0 | 2×TLA; 1×A1ALB; 6×UNX; | |||
| Co-crystal structure of human DDB1 bound to fragment UB028670 | monomer | 100.0 | 2×TLA; 2×VVP; 2×EDO; 5×UNX; | |||
| Crystal Structure of DDB1 | monomer | 99.73 | ||||
| Co-crystal structure of human DDB1 bound to fragment UB028668 | monomer | 100.0 | 2×TLA; 1×A1AK9; 4×UNX; | |||
| Crystal Structure of DNA Damage-Binding protein 1(DDB1) | monomer | 100.0 | ||||
| Crystal Structure of the DDB1 BPB Domain | monomer | 99.68 | ||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6zx9.1.A | monomer | 0.85 | 100.00 | |||
| 6pai.1.A | monomer | 0.84 | 100.00 | |||
| 8tl6.1.A | monomer | 0.60 | 93.90 | |||
2 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 6pai.1.A | monomer | 0.79 | 90.80 | |||
| Isoform 2 | 8tnq.1.A | monomer | 0.61 | 97.22 | |||